期刊文献+

蕈样肉芽肿治疗中国专家共识(2023) 被引量:4

Treatment of mycosis fungoides:a Chinese expert consensus(2023)
原文传递
导出
摘要 蕈样肉芽肿(MF)是皮肤T细胞淋巴瘤最常见类型,早期仅累及皮肤,进展期出现肿块并有淋巴结、外周血和内脏受累。治疗前需对患者进行分期评估,根据分期选择治疗方案。我国12位MF诊疗领域专家在国外最新指南和共识的基础上,回顾了治疗方法的循证医学级别,结合我国现状,在MF一线、二线治疗方案和新疗法等方面达成共识,为规范MF治疗提供指导。 Mycosis fungoides,the most common type of cutaneous T-cell lymphoma,usually only involves the skin at the early stage,and progresses into tumors with involvement of lymph nodes,peripheral blood and the viscera at the advanced stage.A comprehensive stage evaluation should be performed before the initiation of the treatment,and treatment decisions are determined according to the disease stage.Based on the latest international guidelines and consensus,as well as a review of evidence-based treatment options,and combined with current treatment status in China,12 Chinese experts in the field of diagnosis and treatment of mycosis fungoides established this consensus,with an emphasis on first-line and second-line treatment options and novel therapies for mycosis fungoides,so as to provide guidance for standardizing the treatment of mycosis fungoides.
作者 《蕈样肉芽肿治疗中国专家共识(2023)》编写专家组 沈小雁 郑捷 Writing Committee Expert Group on“Treatment of mycosis fungoides:a Chinese expert consensus(2023)”;Shen Xiaoyan;Zheng Jie
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2023年第5期402-409,共8页 Chinese Journal of Dermatology
关键词 淋巴瘤 T细胞 皮肤 蕈样真菌病 肿瘤分期 治疗 专家共识 Lymphoma T-cell cutaneous Mycosis fungoides Neoplasm staging Treatment Expert consensus
  • 相关文献

同被引文献10

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部